Vikram Verghese, Chief Financial Officer of Heartflow, Inc. (NASDAQ:HTFL), filed a Form 4 on September 10, 2026, reporting the sale of 6,640 shares of common stock on September 8, 2026, under a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Shares sold: Vikram Verghese disposed of 6,640 shares of Heartflow, Inc. common stock on September 8, 2026.
  • Weighted average price: The sale was executed at a weighted average price of $50.0319 per share, with individual trades ranging from $50.00 to $50.12.
  • Remaining ownership: Following the transaction, Verghese directly holds 214,503 shares of common stock.
  • 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2026.
  • Role: Verghese is identified in the filing as Chief Financial Officer of Heartflow, Inc.

Heartflow CFO Transaction Details: September 2026 Share Sale

According to the Form 4 filed with the U.S. Securities and Exchange Commission on September 10, 2026, Vikram Verghese, Chief Financial Officer of Heartflow, Inc. (NASDAQ:HTFL), sold 6,640 shares of the company's common stock on September 8, 2026. The filing indicates the transaction was a disposition (Code S), executed directly by the reporting person.

The filing discloses that the sale was carried out in multiple trades at prices ranging from $50.00 to $50.12 per share. The weighted average sale price reported is $50.0319. The filing further notes that Verghese "undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected." Following the reported sale, Verghese directly beneficially owns 214,503 shares of Heartflow common stock.

The filing confirms the transaction was effected pursuant to a Rule 10b5-1 trading plan that Verghese adopted on June 4, 2026. The Form 4 was signed by Nga Van, acting under power of attorney, on September 10, 2026. No derivative securities transactions were reported in this filing.

What Was Disclosed

The filing reports a single open-market sale of 6,640 shares of Heartflow common stock by the company's CFO on September 8, 2026, at a weighted average price of $50.0319 per share, conducted under a pre-established 10b5-1 plan adopted June 4, 2026.